Dr. Laurie Ann Welton, DO

Dr. Welton practices at Adventist Health Portland in Portland, Oregon, part of Adventist Health.

Dr. Welton's NPI, 1215914353, was assigned on December 29, 2005. Dr. Welton graduated from Michigan State University College Of Osteopathic Medicine in 1992. Dr. Welton holds Florida license OS8950.

Dr. Welton's primary practice is Adventist Health Portland, at 10123 Se Market Street, Portland, OR 97216 in Multnomah County. The practice phone is (503) 257-2500.

Dr. Welton's primary practice is Adventist Health Portland in Portland, Oregon, part of Adventist Health. Dr. Welton is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Adventist Health Portland. Dmand AI also links Dr. Welton to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Welton practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Welton's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Welton is board certified in infectious disease by the AOA Board of Internal Medicine. Dmand AI has Dr. Welton's licenses on file in 2 states: Florida and Oregon.

Dmand AI lists acute sinusitis, acute skin infection, bronchitis, cold sores or genital herpes, endocarditis, facial skin infection, hiv/aids and immune deficiency disease among the conditions Dr. Welton treats.

CMS data shows 446,129 Medicare services from Dr. Welton across 24 procedure codes in 2024, for 495 Medicare patients. Medicare paid $841,411 for them.

CMS counts 495 Medicare patients who saw Dr. Welton in 2024. The largest group is 75 to 84, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Welton's median patient age at 70, with 48% women.

In 2024, Dr. Welton wrote 1,184 Medicare Part D claims for 267 patients. 73% of them were for generic drugs. CMS names the drug for 1,001 of them, across 32 drugs with 11 or more claims each, at $1,030,300 in total drug cost. In 2023, CMS named 879 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Welton for performance year 2024, reported individually. Dr. Welton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Welton.

Dmand AI links Dr. Welton to 3 clinical trials, 2 of them phase 2/3 studies. Conditions studied include Bronchiectasis, Mycobacterium avium-intracellulare Infection and Severe Acute Respiratory Syndrome. Open Payments lists research payments to Dr. Welton that name 1 trial.

CMS Open Payments shows 391 general payments to Dr. Welton from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Allergan Inc. paid the most, $15,945. It also lists 8 research payments totaling $1,416 in 2024, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Welton, most recently CMS Stage 1 EHR in 2013.

Dr. Welton graduated from Michigan State University College Of Osteopathic Medicine in 1992. Dr. Welton is a member of AOA.

Dr. Welton is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.